nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—SLC22A11—Methotrexate—esophageal cancer	0.199	0.503	CbGbCtD
Doxycycline—SLC22A8—Methotrexate—esophageal cancer	0.116	0.293	CbGbCtD
Doxycycline—SLC22A6—Methotrexate—esophageal cancer	0.0805	0.204	CbGbCtD
Doxycycline—MMP8—larynx—esophageal cancer	0.0711	0.284	CbGeAlD
Doxycycline—MMP7—exocrine gland—esophageal cancer	0.026	0.104	CbGeAlD
Doxycycline—MMP8—neck—esophageal cancer	0.0188	0.0752	CbGeAlD
Doxycycline—MMP1—neck—esophageal cancer	0.0147	0.0586	CbGeAlD
Doxycycline—MMP7—epithelium—esophageal cancer	0.0113	0.0452	CbGeAlD
Doxycycline—MMP13—digestive system—esophageal cancer	0.0108	0.0431	CbGeAlD
Doxycycline—MMP1—epithelium—esophageal cancer	0.01	0.0399	CbGeAlD
Doxycycline—MMP1—bronchus—esophageal cancer	0.00985	0.0393	CbGeAlD
Doxycycline—MMP8—digestive system—esophageal cancer	0.00976	0.0389	CbGeAlD
Doxycycline—MMP1—smooth muscle tissue—esophageal cancer	0.00963	0.0384	CbGeAlD
Doxycycline—MMP13—lung—esophageal cancer	0.00903	0.036	CbGeAlD
Doxycycline—MMP7—digestive system—esophageal cancer	0.00862	0.0344	CbGeAlD
Doxycycline—MMP8—lung—esophageal cancer	0.00815	0.0325	CbGeAlD
Doxycycline—MMP1—digestive system—esophageal cancer	0.00761	0.0303	CbGeAlD
Doxycycline—MMP7—lung—esophageal cancer	0.0072	0.0287	CbGeAlD
Doxycycline—MMP1—lung—esophageal cancer	0.00635	0.0253	CbGeAlD
Doxycycline—MMP8—lymph node—esophageal cancer	0.00557	0.0222	CbGeAlD
Doxycycline—SLC22A11—digestive system—esophageal cancer	0.00482	0.0192	CbGeAlD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—SOX2—esophageal cancer	0.00258	0.00727	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MET—esophageal cancer	0.00248	0.00701	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—SFN—esophageal cancer	0.00238	0.00671	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP14—esophageal cancer	0.0023	0.00649	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—XRCC3—esophageal cancer	0.00223	0.00629	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—BAX—esophageal cancer	0.00218	0.00615	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—MET—esophageal cancer	0.00206	0.00581	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—RB1—esophageal cancer	0.00203	0.00573	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MET—esophageal cancer	0.00198	0.0056	CbGpPWpGaD
Doxycycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00195	0.0055	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—CREBBP—esophageal cancer	0.0018	0.00507	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—HIF1A—esophageal cancer	0.00179	0.00504	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDKN2A—esophageal cancer	0.00178	0.00504	CbGpPWpGaD
Doxycycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00178	0.00503	CbGpPWpGaD
Doxycycline—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00178	0.00501	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—HIF1A—esophageal cancer	0.00177	0.00498	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP14—esophageal cancer	0.00171	0.00482	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—ERBB2—esophageal cancer	0.00171	0.00482	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—HIF1A—esophageal cancer	0.0017	0.00481	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NOS2—esophageal cancer	0.00161	0.00453	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—esophageal cancer	0.00158	0.00447	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NOS2—esophageal cancer	0.00155	0.00438	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—esophageal cancer	0.00155	0.00437	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CASP8—esophageal cancer	0.00155	0.00437	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—RB1—esophageal cancer	0.00153	0.00433	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CCND1—esophageal cancer	0.00151	0.00426	CbGpPWpGaD
Doxycycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00149	0.0042	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDKN1A—esophageal cancer	0.00146	0.00412	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—CASP8—esophageal cancer	0.00145	0.00409	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CAPZA1—esophageal cancer	0.00141	0.00399	CbGpPWpGaD
Doxycycline—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.0014	0.00396	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—CASP8—esophageal cancer	0.0014	0.00395	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—HIF1A—esophageal cancer	0.00138	0.00389	CbGpPWpGaD
Doxycycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00136	0.00384	CbGpPWpGaD
Doxycycline—CYP3A4—digestive system—esophageal cancer	0.00135	0.00538	CbGeAlD
Doxycycline—MMP1—Integrated Cancer Pathway—BCL2—esophageal cancer	0.00133	0.00375	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—BAX—esophageal cancer	0.00132	0.00374	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—esophageal cancer	0.00131	0.00369	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—HIF1A—esophageal cancer	0.0013	0.00367	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NOS3—esophageal cancer	0.00129	0.00364	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP14—esophageal cancer	0.00125	0.00352	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NOS3—esophageal cancer	0.00125	0.00352	CbGpPWpGaD
Doxycycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—esophageal cancer	0.00124	0.0035	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00124	0.00349	CbGpPWpGaD
Doxycycline—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.00123	0.00348	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—MYC—esophageal cancer	0.00121	0.00341	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—esophageal cancer	0.0012	0.0034	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP14—esophageal cancer	0.0012	0.0034	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ANXA1—esophageal cancer	0.0012	0.0034	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—esophageal cancer	0.0012	0.00339	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—EGFR—esophageal cancer	0.00118	0.00334	CbGpPWpGaD
Doxycycline—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.00114	0.0032	CbGpPWpGaD
Doxycycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—esophageal cancer	0.00113	0.0032	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDKN1A—esophageal cancer	0.0011	0.00311	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.00109	0.00308	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CHEK2—esophageal cancer	0.00105	0.00296	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—esophageal cancer	0.00104	0.00294	CbGpPWpGaD
Doxycycline—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.00104	0.00294	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TGFBR2—esophageal cancer	0.00101	0.00285	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—TP53—esophageal cancer	0.000993	0.0028	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CREBBP—esophageal cancer	0.000983	0.00278	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CYP19A1—esophageal cancer	0.000981	0.00277	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.000972	0.00274	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP14—esophageal cancer	0.000963	0.00272	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—SMAD4—esophageal cancer	0.000957	0.0027	CbGpPWpGaD
Doxycycline—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.000943	0.00266	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ATP1B2—esophageal cancer	0.000936	0.00264	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CREBBP—esophageal cancer	0.000936	0.00264	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.00093	0.00263	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—MYC—esophageal cancer	0.000914	0.00258	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TGFBR2—esophageal cancer	0.000908	0.00256	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ABL1—esophageal cancer	0.000887	0.0025	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000886	0.0025	CbGpPWpGaD
Doxycycline—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.000867	0.00245	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—SMAD4—esophageal cancer	0.000859	0.00243	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—DOCK2—esophageal cancer	0.000847	0.00239	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—EGFR—esophageal cancer	0.000837	0.00236	CbGpPWpGaD
Doxycycline—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.000816	0.0023	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.000813	0.00229	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.00081	0.00229	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—EGFR—esophageal cancer	0.000808	0.00228	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CCND1—esophageal cancer	0.000786	0.00222	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—KDR—esophageal cancer	0.000763	0.00216	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—TP53—esophageal cancer	0.00075	0.00212	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MET—esophageal cancer	0.000733	0.00207	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PFN1—esophageal cancer	0.000731	0.00206	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CCND1—esophageal cancer	0.000727	0.00205	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—EP300—esophageal cancer	0.000723	0.00204	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TP53—esophageal cancer	0.000711	0.00201	CbGpPWpGaD
Doxycycline—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.000682	0.00193	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—PIK3CA—esophageal cancer	0.000677	0.00191	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000675	0.00191	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CDKN1A—esophageal cancer	0.00067	0.00189	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—EP300—esophageal cancer	0.000669	0.00189	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—XBP1—esophageal cancer	0.000666	0.00188	CbGpPWpGaD
Doxycycline—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.000656	0.00185	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—TP53—esophageal cancer	0.000655	0.00185	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CREBBP—esophageal cancer	0.000639	0.00181	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—SLC30A7—esophageal cancer	0.000639	0.0018	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—EP300—esophageal cancer	0.000637	0.0018	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MYC—esophageal cancer	0.00063	0.00178	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.000626	0.00177	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.000626	0.00177	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000618	0.00174	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.000598	0.00169	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CFL1—esophageal cancer	0.000592	0.00167	CbGpPWpGaD
Doxycycline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.000586	0.00165	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—MYC—esophageal cancer	0.000583	0.00165	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000577	0.00163	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000575	0.00162	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000572	0.00161	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—esophageal cancer	0.000564	0.00159	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—GNG7—esophageal cancer	0.000558	0.00158	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.000558	0.00158	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—KDR—esophageal cancer	0.000557	0.00157	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TP53—esophageal cancer	0.000549	0.00155	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—KDR—esophageal cancer	0.000538	0.00152	CbGpPWpGaD
Doxycycline—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.000529	0.00149	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TP53—esophageal cancer	0.000518	0.00146	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.000516	0.00146	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—esophageal cancer	0.000516	0.00146	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000505	0.00143	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000495	0.0014	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—esophageal cancer	0.000479	0.00135	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000475	0.00134	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CCND1—esophageal cancer	0.000473	0.00134	CbGpPWpGaD
Doxycycline—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000468	0.00132	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CDKN1A—esophageal cancer	0.000458	0.00129	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—TP53—esophageal cancer	0.000456	0.00129	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—HSPA5—esophageal cancer	0.000455	0.00128	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.00045	0.00127	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—EP300—esophageal cancer	0.000435	0.00123	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—KDR—esophageal cancer	0.00043	0.00121	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000429	0.00121	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	0.000425	0.0012	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000412	0.00116	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000412	0.00116	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—PIK3CA—esophageal cancer	0.000405	0.00114	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000398	0.00112	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ACTB—esophageal cancer	0.000396	0.00112	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000395	0.00112	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000392	0.00111	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	0.000391	0.0011	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000385	0.00109	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MYC—esophageal cancer	0.000379	0.00107	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000373	0.00105	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000362	0.00102	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—HSPA5—esophageal cancer	0.000358	0.00101	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CALR—esophageal cancer	0.000347	0.000979	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000347	0.000979	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000343	0.000969	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—GHRL—esophageal cancer	0.000341	0.000963	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	0.000341	0.000962	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ABL1—esophageal cancer	0.000337	0.000952	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—FBXW7—esophageal cancer	0.000336	0.000947	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	0.000333	0.000941	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000327	0.000924	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.000322	0.00091	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000321	0.000907	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000314	0.000886	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000314	0.000886	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000312	0.000881	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TP53—esophageal cancer	0.000312	0.00088	CbGpPWpGaD
Doxycycline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000311	0.000878	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000302	0.000853	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000296	0.000836	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000286	0.000809	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000283	0.0008	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000283	0.000799	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000282	0.000797	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	0.00028	0.00079	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00028	0.000789	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.000273	0.000771	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000266	0.00075	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000262	0.00074	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000262	0.00074	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000244	0.00069	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS2—esophageal cancer	0.000243	0.000686	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000238	0.000672	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00023	0.000648	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000228	0.000645	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000225	0.000636	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CREBBP—esophageal cancer	0.000218	0.000616	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000218	0.000615	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.000216	0.000609	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000215	0.000606	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000212	0.000598	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.00021	0.000593	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000199	0.000561	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS3—esophageal cancer	0.000195	0.000552	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000185	0.000523	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000184	0.00052	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—GNG7—esophageal cancer	0.00018	0.000509	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000174	0.000491	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000172	0.000487	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000171	0.000483	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000169	0.000477	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000166	0.000467	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000159	0.000449	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000157	0.000443	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—EP300—esophageal cancer	0.000149	0.00042	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.000132	0.000371	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.00013	0.000366	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000126	0.000356	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000123	0.000348	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000122	0.000344	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000116	0.000326	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—CREBBP—esophageal cancer	0.000111	0.000312	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CA—esophageal cancer	0.00011	0.00031	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—HMOX1—esophageal cancer	0.00011	0.00031	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—esophageal cancer	0.000106	0.0003	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ABCB1—esophageal cancer	0.000105	0.000297	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	9.83e-05	0.000278	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	9.7e-05	0.000274	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	9.25e-05	0.000261	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	9.12e-05	0.000257	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.44e-05	0.000238	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.04e-05	0.000199	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.97e-05	0.00014	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.97e-05	0.00014	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SLC10A2—esophageal cancer	4.22e-05	0.000119	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CA1—esophageal cancer	4.22e-05	0.000119	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CA2—esophageal cancer	3.86e-05	0.000109	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.59e-05	0.000101	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ADH7—esophageal cancer	3.59e-05	0.000101	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.15e-05	8.89e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TYMP—esophageal cancer	3.01e-05	8.5e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.93e-05	8.27e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.85e-05	8.05e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TPI1—esophageal cancer	2.72e-05	7.68e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.72e-05	7.68e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.61e-05	7.37e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.51e-05	7.09e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.49e-05	7.03e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GNG7—esophageal cancer	2.37e-05	6.68e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.22e-05	6.26e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.11e-05	5.96e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.09e-05	5.89e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.98e-05	5.58e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ENO1—esophageal cancer	1.98e-05	5.58e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PSME2—esophageal cancer	1.95e-05	5.5e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PSME1—esophageal cancer	1.95e-05	5.5e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.68e-05	4.75e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.58e-05	4.46e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.44e-05	4.07e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.38e-05	3.91e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CREBBP—esophageal cancer	9.26e-06	2.61e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NOS3—esophageal cancer	8.29e-06	2.34e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—esophageal cancer	7.58e-06	2.14e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—EP300—esophageal cancer	6.3e-06	1.78e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.66e-06	1.32e-05	CbGpPWpGaD
